Clinical Drug Investigation

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease
pp. 235-242(8)
Authors: Konermann M.; Suchantke R.; Mogck J.; Brauburger J.; Bräutigam M.

Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500µg) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus™ in Patients with Moderate to Severe Asthma
pp. 243-255(13)
Authors: van Noord J.A.; Lill H.; Carrillo Diaz T.; Greefhorst A.P.; Davies P.

Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder: A Double-Blind, Randomised Clinical Trial
pp. 257-263(7)
Authors: Vaz-Serra A.; Figueira M.L.; Bessa-Peixoto A.; Firmino H.; Albuquerque R.; Paz C.; Dolgner A.; Vaz-Silva M.; Almeida L.

Pantoprazole Effectively Controls Intra-Oesophageal pH and Promotes Oesophageal Healing: Further Evidence for Ranitidine-Induced Tolerance in Patients with Gastro-Oesophageal Reflux Disease
pp. 265-272(8)
Authors: Awad R.A.; Camacho S.; Dibildox M.

Reliable Acid Suppression with Pantoprazole Contrasts with Rapid Development of Tolerance to Ranitidine in Healthy Individuals
pp. 273-279(7)
Authors: Teyssen S.; Singer M.V.; Pfützer R.; Heinze H.; Fischer R.

Effect of Hormonal Contraceptives on the Pharmacokinetics of Trovafloxacin in Women
pp. 281-286(6)
Authors: Amsden G.W.; Mohamed M.A.; Menhinick A.M.

Bioequivalence Study of Two Formulations (Sachet and Tablet) of Cefixime after Single Oral Doses of 200mg in Healthy Male Volunteers
pp. 287-294(8)
Authors: Evène E.; Brault M.; Manche M.; Sibille M.; Montay G.; Vital Durand D.

Multiple Absorption Patterns of Mesalazine from Two Gastroresistant Tablets in Healthy Male Volunteers: Effects of Food and Formulation
pp. 295-305(11)
Authors: Vree T.B.; Dammers E.; Exler P.S.; Maes R.A.A.

Interferon-Beta in the Treatment of Multiple Sclerosis: Do Clinical Data Support the Existence of a Ceiling Effect?
pp. 307-318(12)
Author: Clanet M.